Sanofi-Aventis SA has warned the management of Genzyme Corp that its shareholders’ interests could be put in jeopardy if certain defensive measures are put in place to stop Sanofi-Aventis’s bid for the company. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals
